APOB and atherosclerosis: The inhibition of anti-miR-34a has been showen to reduce vascular inflammation, senescence, and apoptosis, highlighting their prognostic and therapeutic potential [48] Furthermore, genetic variations in the expression of lipoprotein lipase and its associated modulators, such as apoB, have been independently linked to the development of atherosclerosis [45,46].